Clinical data | |
---|---|
Other names | Hydroxyprogesterone heptanoate benziloylhydrazone; OHPHBH; Hydroxyprogesterone enanthate benzilic acid hydrazone; 17α-Hydroxyprogesterone 17α-heptanoate 3-benzilic acid hydrazone |
Routes of administration | Intramuscular injection |
Drug class | Progestin; Progestogen; Progestogen ester |
Identifiers | |
CAS Number | |
Chemical and physical data | |
Formula | C42H54N2O5 |
Molar mass | 666.903 g·mol−1 |
3D model ( JSmol) | |
| |
|
Hydroxyprogesterone heptanoate benzilic acid hydrazone (OHPHBH), also known as 17α-hydroxyprogesterone 17α-heptanoate 3-benzilic acid hydrazone, is a progestin medication which was never marketed. [1] [2] It is the C3 benzilic acid hydrazone of hydroxyprogesterone heptanoate (OHPH). [1] [2] The medication has a longer duration of action than OHPH when administered by subcutaneous injection in animals. [1] [2]